Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Vor Biopharma Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
08/11/2023 SC 13D/A RA CAPITAL MANAGEMENT, L.P. reports a 33.7% stake in VOR BIOPHARMA INC.
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 4 Chakraborty Tirtha (Chief Scientific Officer) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 875 shares @ $2.67, valued at $2.3k
08/09/2023 4 Jorgensen Nathan D. (CFO) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 834 shares @ $2.67, valued at $2.2k
08/09/2023 4 Attar Eyal C. (Chief Medical Officer) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 999 shares @ $2.67, valued at $2.7k
08/09/2023 4 ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 2,361 shares @ $2.67, valued at $6.3k
06/09/2023 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Successful Primary Engraftment of Trem-cel in First Five AML Patients Demonstrates Promise of Vor Bio's Platform"
06/02/2023 4 RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 30,000 options to buy @ $4.79, valued at $143.7k
06/02/2023 4 Resnick Joshua (Director) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 30,000 options to buy @ $4.79, valued at $143.7k
06/02/2023 4 Patterson Matthew R (Director) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 30,000 options to buy @ $4.79, valued at $143.7k
06/02/2023 4 Lubner David Charles (Director) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 30,000 options to buy @ $4.79, valued at $143.7k
06/02/2023 4 Lundberg Sven Ante (Director) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 30,000 options to buy @ $4.79, valued at $143.7k
06/02/2023 4 Beckman Daniella (Director) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 30,000 options to buy @ $4.79, valued at $143.7k
05/26/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 4 ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 2,361 shares @ $4.14, valued at $9.8k
05/10/2023 4 Chakraborty Tirtha (Chief Scientific Officer) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 875 shares @ $4.14, valued at $3.6k
05/10/2023 4 Jorgensen Nathan D. (CFO) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 834 shares @ $4.14, valued at $3.5k
05/10/2023 4 Attar Eyal C. (Chief Medical Officer) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 969 shares @ $4.14, valued at $4k
04/14/2023 ARS Form ARS - Annual Report to Security Holders:
04/14/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/14/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/14/2023 8-K Quarterly results
03/23/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/02/2023 4 ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 12,657 shares @ $5.51, valued at $69.7k
03/02/2023 4 Chakraborty Tirtha (Chief Scientific Officer) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 5,576 shares @ $5.51, valued at $30.7k
03/02/2023 4 Jorgensen Nathan D. (CFO) has filed a Form 4 on Vor Biopharma Inc.
Txns: Paid exercise price by delivering 6,310 shares @ $5.51, valued at $34.8k
02/14/2023 SC 13G/A Paradigm Biocapital Advisors LP reports a 9.9% stake in Vor Biopharma Inc.
02/08/2023 4 ANG ROBERT (President and CEO) has filed a Form 4 on Vor Biopharma Inc.
Txns: Granted 128,750 shares @ $0
Granted 257,500 options to buy @ $5.55, valued at $1.4M
02/08/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/08/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/08/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/10/2023 SC 13G/A FMR LLC reports a 12.1% stake in VOR BIOPHARMA INC
12/21/2022 EFFECT Form EFFECT - Notice of Effectiveness:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy